WADA prohibited list raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-09-04 and is reviewed periodically as new material appears.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form; may appear as cake |
| Solubility class | Water-soluble | Often reconstituted in aqueous buffer |
| Typical storage temperature | −20 °C or below | Protect from light and moisture |
| Typical analytical method | RP-HPLC and mass spectrometry | Used for purity and identity |
| Common synonyms | AOD-9604; AOD9604; hGH fragment 176-191 | Research name and fragment description |
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
Allmusic's Brian Olewnick called it "Either/Orchestra's finest, most accomplished release" and said: "Beautifully recorded by legendary engineer Rudy van Gelder, the band is extraordinarily tight and vibrant, showing none of the muddy quality that would sully some of their later work ... Quite a journey, resulting in arguably the best of this unusual band's release. Very highly recommended".
== Evolution == Vertebrates started off with a single copy of the vitellogenin gene, and the bird-mammalian and amphibian lineages each experienced duplications that gave rise to the modern genes. With the exception of monotremes, mammals have all their vitellogenin genes turned into pseudogenes, although the region syntenic to bird VIT1-VIT2-VIT3 can still be found and aligned. In monotremes just one of the genes remained functional.
=== Youth === East German Junior Championship (de) Winners: 1961, 1971, 1974, 1976, 1977 Runners-up: 1964, 1972, 1982 East German Youth Championship (de) Winners: 1969, 1971, 1979, 1981, 1984 (record) Runners-up: 1966, 1970, 1978, 1980 East German Junior Cup (Junge Welt-Pokal) (de) Winners: 1971, 1974, 1975, 1988 East German Youth Cup (Youth FDGB-Pokal) Winners: 1959, 1968
=== Redox === Graphene oxide can be reversibly reduced and oxidized via electrical stimulus. Controlled reduction and oxidation in two-terminal devices containing multilayer graphene oxide films are shown to result in switching between partly reduced graphene oxide and graphene, a process that modifies electronic and optical properties. Oxidation and reduction are related to resistive switching.
Sources: en.wikipedia.org
== Neuromodulator == GSSG, along with glutathione and S-nitrosoglutathione (GSNO), have been found to bind to the glutamate recognition site of the NMDA and AMPA receptors (via their γ-glutamyl moieties), and may be endogenous neuromodulators. At millimolar concentrations, they may also modulate the redox state of the NMDA receptor complex.
=== Absorption and distribution in the body === Following oral administration, alitretinoin exhibits variable absorption, which is increased when taken with food. It is extensively bound to plasma proteins. Metabolism occurs in the liver via CYP3A4, forming 4-oxoalitretinoin. The half-life ranges from 2 to 10 hours, and elimination occurs primarily renally. No significant systemic distribution is observed after dermal application.
Operating a CH station was a manpower-intensive situation, with an operator in the transmitter hut, an operator and assistant in the receiver hut, and as many as six assistants in the receiver hut operating the plotters, calculators and telephone systems. In order to provide 24-hour service, multiple crews were needed, along with a number of service and support personnel. This was then multiplied by the reporting hierarchy, which required similar numbers of WAAFs at each level of the Dowding system hierarchy. Plotting the angle of the target was a simple process of taking the gonio reading and setting a rotating straightedge to that value. The problem was determining where along that straightedge the target lay; the radar measured the slant range straight-line distance to the target, not the distance over the ground. That distance was affected by the target's altitude, which had to be determined by taking the somewhat time-consuming altitude measurements. Additionally, that altitude was affected by the range, due to the curvature of the Earth, as well as any imperfections in the local environment, which caused the lobes to have different measurements depending on the target angle. As no small part of the manpower required was dedicated to calculation and plotting, a great reduction could be made by using as much automation as possible. This started with the use of various mechanical aids; these were eventually replaced by the fruit machine, an electromechanical analogue computer of some complexity. It replicated all of these devices and tables in electrical form.
Their mission, in their words "for the purpose of mutual aid in cases of sickness, accident and death of its members or their families". In 1923 it had 8,000 members in 60 subordinate societies; that year it had a capital of over $500,000, with a further $100,000 in sick benefit funds held by local societies. All policy decisions are determined by a "Central Society" made up of the officers, founders, and representatives of the subordinate lodges. A central society meets at stated intervals to elect officers to administer the group and make needed changes. Membership is open to men 18–50, of good moral character who have passed medical exams, regardless of religious or political creeds. Germania stated that it "is not a secret society. No pass-words or grips feature its work. In fact, any man is welcome to join its meetings." German Order of Harugari Greater Beneficial Union of Pittsburgh - Incorporated April 14, 1892 in Allegheny County, Pennsylvania, as the Deutscher Unter-stuetzungs-Bund, within a month had 243 members in 6 districts. Began the periodical, Union Reporter, the next year, now known as GBU Reporter. Rituals include the candidate signing an application and the president of the local lodge giving an address about the privileges of membership and how one should enter the lodge. Union claimed to be non-sectarian and had no secrets; open to all "well-meaning persons"; non-members accompanied by members allowed at meeting.
Calciphylaxis, also known as calcific uremic arteriolopathy (CUA) or “Grey Scale”, is a rare syndrome characterized by painful skin lesions. The pathogenesis of calciphylaxis is unclear but believed to involve calcification of the small blood vessels located within the fatty tissue and deeper layers of the skin, blood clots, and eventual death of skin cells due to lack of blood flow. It is seen mostly in people with end-stage kidney disease but can occur in the earlier stages of chronic kidney disease and rarely in people with normally functioning kidneys. Calciphylaxis is a rare but serious disease, believed to affect 1-4% of all dialysis patients. It results in chronic non-healing wounds and indicates poor prognosis, with typical life expectancy of less than one year. Calciphylaxis is one type of extraskeletal calcification. Similar extraskeletal calcifications are observed in some people with high levels of calcium in the blood, including people with milk-alkali syndrome, sarcoidosis, primary hyperparathyroidism, and hypervitaminosis D. In rare cases, certain medications such as warfarin can also result in calciphylaxis.
Sources: en.wikipedia.org
Lyophilized powder is commonly stored at −20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept refrigerated and used within a limited period.
Reversed-phase HPLC and mass spectrometry are standard checks. They confirm peptide purity and molecular mass, but they do not by themselves demonstrate biological activity.
Synthesis, purification, and handling conditions can differ, leading to variations in purity and salt content. Certificates of analysis help, but independent testing is often needed for verification.
No. Major drug regulators have not approved AOD-9604 for weight loss or any other therapeutic indication. It remains an investigational compound studied in research settings.